don't get scammed by Mount Sinai et al.
search pubmed.org for lung cancer aspirin and metformin and you will see that metformin and aspirin will treat or better lung cancer and other types of cancer. scanning does not address the utility of this save and effective way to kill abberrant cancer cells. a scan should not be viewed simply as a profit center to deliver news. if the person scanned dies then there are plenty more people to be scanned.
why doesn't Delthia Ricks and Newsday help advance the safe inexpensive and effective treatment for lung cancer et al, metformin and apsirin?
if you are a terminal cancer patient you might consider aspirin and metformin and publish your results on You Tube. If/when it works better than anything else you may have tried you will wonder how humans treat each other.
Aspirin and metformin, inexpensive, safe, and effective and should be tried before employing lead to the head for a guaranteed result.
Annual CT scans for lung cancer recommended for longtime smokers
Photo credit: Getty Images | Smokers who've indulged in the
habit for decades can benefit from routine annual low-dose CT screenings
to detect the presence of early-stage lung cancers, a key government
health panel said. (Sept. 15, 2009)
Smokers who've indulged in the habit
for decades can benefit from routine annual low-dose CT screenings to
detect the presence of early-stage lung cancers, a key government health
panel said Monday.
The draft recommendation by the U.S.
Preventive Services Task Force is open for public comment until Aug. 26.
The final statement is expected to be officially published within three
to six months.
Older smokers and former smokers -- 55
to 74 -- with a pack-a-day history should undergo annual helical CT
scans, according to the task force, which estimates about 9 million
people are probably eligible for screening.
BLOG: The Daily Apple |
PHOTOS: Dropping LBs
DATA: Explore hospital rankings | Narcotics by community
WEIGH IN: Ask your fitness questions
Panelists based their recommendation on the National
Lung Screening Trial, a massive nationwide study of 53,000 current and
former smokers. Researchers concluded in 2010 that screening reduced
lung cancer deaths by 20 percent.
A second national study, a portion of
which was conducted on Long Island, helped determine which types of lung
nodules detected by CT scans should be biopsied to help prevent
unnecessary invasive procedures.
The new screening endorsement by the influential government panel has been a long time coming.
In 2004, the task force gave the
screening its lowest possible recommendation, saying there wasn't enough
evidence to prove its worth. But Monday, the independent panel of
nonfederal experts, which makes recommendations to primary care
clinicians on screenings, counseling and preventive medications, gave
the scans a grade of "B" -- a full-throated endorsement.
"Finally. Good for them," said Dr.
Shahriyour Andaz, director of thoracic oncology at South Nassau
Communities Hospital in Oceanside.
"The purpose of CT screening is to
detect lung cancer early," said Andaz, who is also an associate
professor of surgery at Hofstra-North Shore LIJ School of Medicine. He
led the Long Island portion of the Early Lung Cancer Action Program,
which helped determine the types of lung nodules that should be
biopsied.
"You're not preventing lung cancer
through CT scanning, you're detecting it at hopefully stage 1A," added
Andaz, noting that long-term survival is most likely when tumors are
spotted in their earliest evolutionary phase.
For Dr. Claudia Henschke, director of
the Lung and Cardiac Screening Program at The Mount Sinai Medical Center
in Manhattan, the panel's recommendation is vindication of her
pioneering research.
She is the first doctor to theorize -- and prove 14 years ago -- that CT scanning saves lives.
For years, skeptics had denounced CT
scans for lung cancer, complaining that patients would run the risk of
false positives and invasive procedures that could prove costly and
disabling. But the scientific evidence overwhelmingly showed lives were
spared.
"The decision by the . . . [panel] to
upgrade its recommendation for low-dose CT screening for lung cancer to a
'B' is a major step forward," Henschke said. "The benefits associated
with CT screening, while still not fully appreciated, will continue to
improve over time."
Dr. Nabil Rizk, a thoracic surgeon at
Memorial Sloan-Kettering Cancer Center in Manhattan, said the panel's
decision is good news for smokers -- and physicians"This is for people
with a 30-year history of smoking," Rizk said.
. With the panel's recommendation,
Rizk predicts Medicare and private insurers will probably cover the
screening's cost, which can run anywhere from $500 to $750.
Lung cancer is a major disease burden
that kills about 160,000 people annually, more than those who die from
breast, prostate and colorectal cancers combined.
"Lung cancer is the leading cause of
cancer death in the United States and a devastating diagnosis for more
than 200,000 people each year," said Dr. Virginia Moyer, who chairs the
task force. "Sadly, nearly 90 percent of people who develop lung cancer
die from the disease, in part because it often is not found until it is
at an advanced stage," she said.